Cargando…

Patient-Reported Disease Severity and Quality of Life Among Arabic Psoriatic Patients: A Cross-Sectional Survey

PURPOSE: Patient-reported measures are of importance in chronic dermatological conditions where psychosocial consequences and quality of life impairment are common. The current study aimed to evaluate patient-reported disease severity and quality of life in Arabic patients with psoriasis. PATIENTS A...

Descripción completa

Detalles Bibliográficos
Autor principal: Soliman, Moetaza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473981/
https://www.ncbi.nlm.nih.gov/pubmed/32943898
http://dx.doi.org/10.2147/CCID.S269909
_version_ 1783579262101487616
author Soliman, Moetaza
author_facet Soliman, Moetaza
author_sort Soliman, Moetaza
collection PubMed
description PURPOSE: Patient-reported measures are of importance in chronic dermatological conditions where psychosocial consequences and quality of life impairment are common. The current study aimed to evaluate patient-reported disease severity and quality of life in Arabic patients with psoriasis. PATIENTS AND METHODS: Arabic psoriatic patients were invited to complete an online survey that collected patients’ demographics, self-assessed Simplified Psoriasis Index (saSPI) and the Dermatology Life Quality Index (DLQI). Disease severity and quality of life were compared in relation to patients’ demographics. Correlation between patient-reported measures was calculated using Spearman’s rank correlation test. RESULTS: A total of 221 patients with psoriasis, from 12 Arabic-speaking countries, participated in the study. The mean (95% CIs) saSPI-severity score was 10.9 (9.6–12.2). Female patients reported higher saSPI-psychosocial impact scores compared to males (P=0.04) while patients with longer disease duration reported higher saSPI-past history and interventions scores (P=0.0001). The mean (95% CIs) DLQI score was 11.2 (10.2–12.1). Patients with severe disease reported significantly higher DLQI scores [18.5 (10.5–2)] (P=0.0001). DLQI was strongly correlated with saSPI-psychosocial impact score (rho= 0.63). CONCLUSION: Arabic psoriatic patients participating in this study showed mild to moderate disease severity which had a very large impact on patients’ quality of life. Higher disease severity was associated with more impaired quality of life.
format Online
Article
Text
id pubmed-7473981
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-74739812020-09-16 Patient-Reported Disease Severity and Quality of Life Among Arabic Psoriatic Patients: A Cross-Sectional Survey Soliman, Moetaza Clin Cosmet Investig Dermatol Original Research PURPOSE: Patient-reported measures are of importance in chronic dermatological conditions where psychosocial consequences and quality of life impairment are common. The current study aimed to evaluate patient-reported disease severity and quality of life in Arabic patients with psoriasis. PATIENTS AND METHODS: Arabic psoriatic patients were invited to complete an online survey that collected patients’ demographics, self-assessed Simplified Psoriasis Index (saSPI) and the Dermatology Life Quality Index (DLQI). Disease severity and quality of life were compared in relation to patients’ demographics. Correlation between patient-reported measures was calculated using Spearman’s rank correlation test. RESULTS: A total of 221 patients with psoriasis, from 12 Arabic-speaking countries, participated in the study. The mean (95% CIs) saSPI-severity score was 10.9 (9.6–12.2). Female patients reported higher saSPI-psychosocial impact scores compared to males (P=0.04) while patients with longer disease duration reported higher saSPI-past history and interventions scores (P=0.0001). The mean (95% CIs) DLQI score was 11.2 (10.2–12.1). Patients with severe disease reported significantly higher DLQI scores [18.5 (10.5–2)] (P=0.0001). DLQI was strongly correlated with saSPI-psychosocial impact score (rho= 0.63). CONCLUSION: Arabic psoriatic patients participating in this study showed mild to moderate disease severity which had a very large impact on patients’ quality of life. Higher disease severity was associated with more impaired quality of life. Dove 2020-08-25 /pmc/articles/PMC7473981/ /pubmed/32943898 http://dx.doi.org/10.2147/CCID.S269909 Text en © 2020 Soliman. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Soliman, Moetaza
Patient-Reported Disease Severity and Quality of Life Among Arabic Psoriatic Patients: A Cross-Sectional Survey
title Patient-Reported Disease Severity and Quality of Life Among Arabic Psoriatic Patients: A Cross-Sectional Survey
title_full Patient-Reported Disease Severity and Quality of Life Among Arabic Psoriatic Patients: A Cross-Sectional Survey
title_fullStr Patient-Reported Disease Severity and Quality of Life Among Arabic Psoriatic Patients: A Cross-Sectional Survey
title_full_unstemmed Patient-Reported Disease Severity and Quality of Life Among Arabic Psoriatic Patients: A Cross-Sectional Survey
title_short Patient-Reported Disease Severity and Quality of Life Among Arabic Psoriatic Patients: A Cross-Sectional Survey
title_sort patient-reported disease severity and quality of life among arabic psoriatic patients: a cross-sectional survey
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473981/
https://www.ncbi.nlm.nih.gov/pubmed/32943898
http://dx.doi.org/10.2147/CCID.S269909
work_keys_str_mv AT solimanmoetaza patientreporteddiseaseseverityandqualityoflifeamongarabicpsoriaticpatientsacrosssectionalsurvey